Medication info
Clopidogrel Tablets (Clopidogrel Bisulfate)

Clopidogrel Tablets (Clopidogrel Bisulfate)

Prescription medicationTablet
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201505737 · Approved 2015.08.17 · Insurance code 671704790

Summary

Main use
Improvement of acute coronary syndrome and symptoms of atherosclerosis; prevention of thromboembolism in atrial fibrillation
Who uses it
Adults
Adult dosage
1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), on the first day of treatment with this medicine, start with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. In patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: There is limited treatment experience in patients with renal impairment. ○ Patients with hepatic impairment: There is limited treatment experience in patients with moderate hepatic disease with a bleeding diathesis. This medicine may be administered with or without food.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of acute coronary syndrome and symptoms of atherosclerosis; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-ST elevation myocardial infarction
  • cardiovascular anomalies
  • stroke
  • refractory ischemia
  • atrial fibrillation
View approved original text

This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. Additionally, it helps improve cardiovascular atherosclerotic symptoms in patients with acute coronary syndrome who have unstable angina or non-ST elevation myocardial infarction and receive or are scheduled to receive drug treatment, percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG). Furthermore, in adult patients with one or more vascular risk factors where vitamin K antagonist therapy is inappropriate and with a low risk of bleeding, it reduces the risk of stroke and thromboembolism. In summary, this medication is used to improve atherosclerotic symptoms related to vascular diseases and reduce the risk of stroke and thrombosis to restore health.

Dosage and Administration

Adult dosage

1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), on the first day of treatment with this medicine, start with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. In patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: There is limited treatment experience in patients with renal impairment. ○ Patients with hepatic impairment: There is limited treatment experience in patients with moderate hepatic disease with a bleeding diathesis. This medicine may be administered with or without food.

Precautions

This medication prevents platelets from aggregating, thus preventing blood from clotting. People with genetically decreased functionality of a specific enzyme (CYP2C19) may experience a reduced effect of this medication, which can increase the risk of heart attack or stroke; therefore, in such cases, treatment methods should be adjusted in consultation with a doctor. Taking this medication with drugs that activate enzymes can increase the concentration of this medication, raising the risk of bleeding, so it is advisable not to take them together. Patients who have an allergy to this medication or its components, those with bleeding disorders, severe liver damage, nursing women, or those with lactose intolerance should not take this medication. Patients at high risk of bleeding or those suspected of having bleeding symptoms should immediately undergo blood tests, and for those scheduled for surgery, it is recommended to discontinue this medication 5-7 days prior and restart only after hemostasis. Caution is required when taking this medication with other bleeding risk medications, anticoagulants, or certain antidepressants, as the risk of bleeding may increase. This medication may cause side effects related to bleeding such as gastrointestinal bleeding, bruising, nosebleeds, hematuria, thus should consult a doctor immediately if any abnormal symptoms occur. Pregnant women are advised to discontinue this medication 5-7 days prior to delivery due to an increased risk of bleeding during childbirth. In nursing mothers, as this medication may be excreted in breast milk, careful consideration should be given on whether to discontinue nursing or the medication. Elderly patients or those with impaired kidney or liver function may have an increased risk of bleeding, hence dosage adjustments and condition monitoring are necessary. In overdose situations, the risk of bleeding increases, and since there is no specific antidote, measures such as platelet transfusion may be necessary in case of significant bleeding. To ensure safety for children, this medication should be stored out of reach of children, and transferring it to another container may alter its quality, so caution is advised.

Side effects

Hemorrhage, gastrointestinal bleeding, bleeding requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, major hemorrhage, mild hemorrhage, severe hemorrhage, fatal hemorrhage, hemorrhagic stroke, thrombocytopenia, neutropenia, agranulocytosis, aplastic anemia, skin rash, pruritus, diarrhea, abdominal pain, dyspepsia, nausea, headache, dizziness, depression, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, purpura disease, blood in stool, platelet reduction, anemia, visual disturbances, visual field defects, dry eyes, temporary blindness, congestion, tinnitus, decreased motor function, tremor, speech disturbance, abnormal gait, hyperkinesis, ataxia, insomnia, forgetfulness, anxiety, delirium, abnormal thoughts, abnormal behavior, rigidity, hiccups, dysphagia, tongue disorders, gynecomastia, elevated PSA, cholecystitis, hematemesis, spinal hematoma, allergic symptoms, ischemic necrosis, generalized edema, gastritis, hemorrhagic gastritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal tract ulcer bleeding, distension, bilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hemoptysis, retroperitoneal hemorrhage, surgical wound bleeding, pulmonary hemorrhage, thrombocytopenia, hypochromic anemia, leukemia, leukopenia, eosinophilia, menorrhagia, hemothorax, herpes zoster, erythematous rash, maculopapular rash, urticaria, renal dysfunction, acute renal failure, fever

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air, ideally at room temperature between 1 degree and 30 degrees. By storing it this way, the effectiveness of the medication is maintained for safe use.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.